Report
Johannes Grunselius
EUR 87.07 For Business Accounts Only

BillerudKorsnäs (Buy, TP: SEK205.00) - Start of a new chapter

We expect growth in underlying profits QOQ in Q2 as higher prices more than offset increased input costs (Q2 will also see the inclusion of the highly profitable US operations, explaining why we expect c170% growth in reported EBITDA YOY). We have made relatively few changes to our 2022–2024 earnings scenario, and continue to see an attractive value and growth case underpinned by megatrends. We reiterate our BUY and SEK205 target price.
Underlying
BillerudKorsnas AB

Billerud Korsnas Aktiebolag Public is a provider of packaging products and services. Co. has three business areas: Packaging Paper, which provides kraft and sack paper, as well as functional solutions for several applications, including packaging for foodstuffs, industrial purposes, medical applications and carrier bags, and also sells surplus of pulp that Co. does not use in its own production; Consumer Board, which develops and markets cartonboard used in packaging for beverages, yoghurt, refrigerated and frozen food products and other consumer goods; and Containerboard, which provides corrugated board raw material that provides packaging for transportation uses and primary packaging.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Johannes Grunselius

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch